Management of prostate cancer patients with locally adverse pathologic features after radical prostatectomy: feasibility of active surveillance for cases with Gleason grade 3 + 4 = 7-Reference-Cited by-同舟云学术

Management of prostate cancer patients with locally adverse pathologic features after radical prostatectomy: feasibility of active surveillance for cases with Gleason grade 3 + 4 = 7

Published:2016-09-20 Issue:1 Volume:143 Page:123-129
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Shangguan Xun,Dong Baijun,Wang Yanqing,Xu Fan,Shao Xiaoguang,Sha Jianjun,Zhu Yinjie,Pan Jiahua,Xue Wei

Funder

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support

Key Disciplines Group Construction Project of Pudong Health Bureau of Shanghai

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00432-016-2262-9.pdf

Reference28 articles.

1. Audenet F, Seringe E, Drouin SJ et al (2012) Persistently elevated prostate-specific antigen at six weeks after radical prostatectomy helps in early identification of patients who are likely to recur. World J Urol 30:239–244

2. Bolla M, van Poppel H, Tombal B et al (2012) Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911). Lancet (London, England) 380:2018–2027

3. Chan TY, Partin AW, Walsh PC, Epstein JI (2000) Prognostic significance of Gleason score 3 + 4 versus Gleason score 4 + 3 tumor at radical prostatectomy. Urology 1(56):823–827

4. de Boo L, Pintilie M, Yip P, Baniel J, Fleshner N, Margel D (2015) Time from first detectable PSA following radical prostatectomy to biochemical recurrence: a competing risk analysis. Can Urol Assoc J 9:E14–E21

5. Dillioglugil O, Leibman BD, Kattan MW, Seale-Hawkins C, Wheeler TM, Scardino PT (1997) Hazard rates for progression after radical prostatectomy for clinically localized prostate cancer. Urology 50:93–99

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of prostate and breast cancer detection artificial intelligence algorithms for accurate histopathological diagnosis and grading: a retrospective study with a Japanese cohort;Pathology;2024-08

2. Organ-confined pT2 ISUP4/5 vs. nonorgan confined pT3/4 ISUP2 vs. ISUP3 prostate cancer: Differences in biochemical recurrence-free survival after radical prostatectomy;Urologic Oncology: Seminars and Original Investigations;2024-07

3. Neoplasms of the Prostate;Urologic Surgical Pathology;2020

4. Cell cycle progression score improves risk stratification in prostate cancer patients with adverse pathology after radical prostatectomy;Journal of Cancer Research and Clinical Oncology;2019-11-19

5. Current Treatment for Low-Risk Prostate Cancer in China: A National Network Survey;Journal of Cancer;2019